Literature DB >> 16450540

[Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].

A Ben Abdelaziz1, I Harrabi, S Rahmani, A Ghedira, K Gaha, H Ghannem.   

Abstract

The therapeutic knowledge of physicians is the corner stone to the rational use of medicines; however information about medicines is generally obtained from the pharmaceutical industry via their sales representatives (reps). We aimed to identify general practitioners' (GPs) attitudes to pharmaceutical reps and the information they provide. We surveyed 140 GPs using a self-administered questionnaire. The response rate was 78% (72 GPs from the public sector and 68 from the private sector). About 10% of the GPs said they received daily visits from pharmaceutical reps; 84% of GPs considered them an efficient source of information and 31% said they might change their therapeutic prescribing following visits from these reps. Because of their positive perception of pharmaceutical reps, GPs are susceptible to the information they provide. Controlling the validity of the therapeutic information imparted by the pharmaceutical industry is thus a fundamental component of the programme for the rational use of medicines.

Mesh:

Year:  2003        PMID: 16450540

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  5 in total

1.  Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities.

Authors:  Susan Kamal; Christine Holmberg; Jean Russell; Tomasz Bochenek; Beata Tobiasz-Adamczyk; Christiane Fischer; Peter Tinnemann
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

2.  Towards Patient-Centered Conflicts of Interest Policy.

Authors:  Peter D Young; Dawei Xie; Harald Schmidt
Journal:  Int J Health Policy Manag       Date:  2018-02-01

3.  A survey of pharmaceutical company representative interactions with doctors in Libya.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-09-18       Impact factor: 1.657

4.  What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Authors:  Mustafa Ali Alssageer; Stefan Robert Kowalski
Journal:  Pan Afr Med J       Date:  2013-04-06

5.  Doctors' opinions of information provided by Libyan pharmaceutical company representatives.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-11-28       Impact factor: 1.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.